0.532
-0.02 (-4.09%)
| Penutupan Terdahulu | 0.555 |
| Buka | 0.555 |
| Jumlah Dagangan | 231,589 |
| Purata Dagangan (3B) | 341,175 |
| Modal Pasaran | 8,359,570 |
| Harga / Jualan (P/S) | 0.310 |
| Harga / Buku (P/B) | 0.810 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2025 |
| Margin Keuntungan | -108.21% |
| Margin Operasi (TTM) | -96.40% |
| EPS Cair (TTM) | -3.06 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -4.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.35% |
| Nisbah Semasa (MRQ) | 2.18 |
| Aliran Tunai Operasi (OCF TTM) | -19.54 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -9.87 M |
| Pulangan Atas Aset (ROA TTM) | -27.52% |
| Pulangan Atas Ekuiti (ROE TTM) | -93.11% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | Lifeward Ltd. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 0.17 |
|
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 2.49% |
| % Dimiliki oleh Institusi | 2.44% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 09 Sep 2025 | Pengumuman | First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton |
| 08 Sep 2025 | Pengumuman | Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton |
| 14 Aug 2025 | Pengumuman | Lifeward Ltd. Reports Second Quarter 2025 Financial Results |
| 13 Aug 2025 | Pengumuman | Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |